CONDUIT PHARMACEUTICALS INC
Filed Sep 4, 2024.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed Sep 4, 2024
Contents
EXPERTS
The financial statements of Conduit Pharmaceuticals Inc. as of December 31, 2023, and 2022, and for the years then ended included in this registration statement have been so included in reliance on the report of Marcum LLP, an independent registered public accounting firm (which contains an explanatory paragraph relating to the Company’s ability to continue as a going concern, as described in Note 1 to the financial statements), given on the authority of said firm as experts in auditing and accounting.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.